-
Now and Next in Type 2 Diabetes
Suzanne Elvidge
May 06, 2025
Type 2 diabetes, the most common form of diabetes, affects more than 800 million adults worldwide.
-
The Global Alpha-Glucosidase Inhibitor Market: Trends and Prospects
David Orchard-Webb
March 18, 2025
Alpha-glucosidase inhibitors are used for type 2 diabetes. This article analyzes their market, including growth, segments, and challenges.
-
Proposal to Have Empagliflozin as Option for Children with Type 2 Diabetes
SHEM OIRERE
April 19, 2023
Manufacturers of Jardiance, which contains the drug empagliflozin, which is used in the treatment of diabetes in adults, seeking approval in the US to make a version of the medicine to meet increasing demand from this group of young diabetes patients.
-
HighTide Therapeutics Announces Publication of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus Open
ACN Newswire
March 05, 2025
HighTide Therapeutics announced that Phase 2 data of berberine ursodeoxycholate for treating T2DM was published in JAMA Network Open.
-
Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes
prnasia
January 06, 2022
Metavention, Inc. announces the completion of enrollment in the DeLIVER U.S. Study (NCT04285554), to evaluate the safety of sympathetic denervation of the liver using its new Integrated Radio Frequency (iRF) Denervation System.
-
Positive CHMP opinion for finerenone as new treatment for chronic kidney disease and type 2 diabetes
pharmatimes
December 20, 2021
It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide.
-
Type 2 Diabetes Is Common Comorbidity in Psychiatric Disorders
Drugs
December 09, 2021
For people with psychiatric disorders, type 2 diabetes is a common comorbidity, especially among those with a sleep disorder or binge eating disorder, according to research published online Nov. 29 in Diabetologia.
-
Sit All Day for Work? Simple Step Can Cut Your Health Risk
drugs
August 17, 2021
Take a work break: A small, new study suggests that getting out of your chair every half hour may help improve your blood sugar levels and your overall health.
-
Type 2 Diabetes in Teens Can Bring Dangerous Complications in 20s
drugs
July 30, 2021
Children diagnosed with type 2 diabetes face a high likelihood of developing complications before age 30, a new study suggests.
-
FDA Approves Pediatric Type 2 Diabetes Treatment
americanpharmaceuticalreview
July 26, 2021
The U.S. FDA approved Bydureon and Bydureon BCise (exenatide extended-release) injection to be used in addition to diet and exercise to improve glycemic control (blood sugar levels) in pediatric patients 10 years or older with type 2 diabetes.